Revenio Group Oyj (OTCPK:REVXF)
$ 16.41 (0%) Market Cap: 408.15 Mil Enterprise Value: 389.24 Mil PE Ratio: 21.29 PB Ratio: 2.84 GF Score: 82/100

Half Year 2025 Revenio Group Oyj Earnings Call Transcript

Aug 7, 2025 / 12:00 PM GMT
Release Date Price: $31.47

Key Points

Positve
  • Revenio Group Oyj (REVXF) reported a top-line sales growth of 4.2% in Q2 2025, with a currency-adjusted growth of 7.2%.
  • All regions, including the USA, Europe, Middle East, Africa, and APEC, experienced growth, with notable performance in India, France, and Germany.
  • All product categories, including tonometers, fundus imaging, perimetry, micro perimetry, and software, showed growth.
  • Profitability improved with an EBIT level of €6.1 million, up roughly 16% year-over-year.
  • The company successfully launched the micro perimeter and received marketing authorizations in major markets.
Negative
  • The company faces a 15% tariff impact, which could affect profitability if no price adjustments are made.
  • EPS appears weak due to unrealized foreign exchange losses amounting to €2.5 million in the first half.
  • The company has not yet restarted reimbursement discussions for its Home2 product in the US.
  • The FDA approval process for the DRS Plus is delayed, with expected completion now pushed to mid-2027.
  • Acquisition efforts have been challenging due to valuation mismatches, delaying potential growth through acquisitions.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

REG1V.HE - Revenio Group Oyj
Half Year 2025 Revenio Group Oyj Earnings Call
Aug 07, 2025 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good sunny afternoon, from, Finland, and welcome to revenue, group Q2 2025 earnings call. My name is Yoni Toyella. I'm the, group CEO and with me, as always, we have here Robin Pulkinen.

Our CFO.

Let's.

Go through the agenda first. So I'll start with the highlights for the Q2 2025. And then also, I'm going to cover the summary of the first half. Then Robin is going to do a bit more deeper dive to the Q2.

Financial part, plus the shareholders, and then, reiterate the guidance for 2025 and then of course we finalize the day with the Q&A.

Back to you too, so April, June highlights, so.

Given all turbulence on the tariff side geopolitical side, Q2 went reasonably well in our
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot